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Variable–carbon-chain–length para-substi-
tuted alkylphenols and bisphenol A (BPA) 
are a structurally related group of xeno- 
estrogens (Figure 1) that accumulate in the 
environment from the use of some detergents, 
paints, herbicides, pesticides, and plastic poly-
mers. This includes BPA, 4-n-octyl  phenol 
(OP), and 4-n-nonyl  phenol (NP) (Tsai 
2006; White et al. 1994). They can also 
bio  degrade from phytoestrogens or hydro-
carbon pollu  tants, such as 4-n-ethyl  phenol 
(EP) and 4-n-propylphenol (PP) (Burback 
and Perry 1993; Lundh et al. 1990). These 
chemicals frequently persist in air, soil, and 
aquatic environ  ments in concentrations that 
can affect the reproductive health of animals, 
and probably humans (Ahel et al. 2000; 
Cincinelli et al. 2003, 2007; Clark et al. 
1992; deJager et al. 1999a, 1999b; Dekant 
and Voelkel 2008; Han et al. 2004; Hossaini 
et al. 2001; Isobe et al. 2001; Moon et al. 
2007; Routledge and Sumpter 1997; Tsai 
2006; Ying et al. 2002). Although these com-
pounds are best known for disrupting repro-
ductive functions, they are increasingly found 
to affect nonreproductive functions regulated 
by estrogens, as well (Watson et al. 2007a). 
Alkylphenol xenoestrogens are becoming ever 
more environ  mentally ubiquitous, owing to 
their chemical stability and bioaccumulation; 
they are also stored in the body fat of animals 
and humans (Ahel et al. 1993; Calafat et al. 
2005; Tan and Mohd 2003; Ye et al. 2006). 
Their importance as contaminants and the 
study of their biological effects are increas-
ingly complicated by their further modifica-
tion by chlorination in manufacturing and 
wastewater treatment plants (Fukazawa et al. 
2001; Gallard et al. 2004; Gross et al. 2004; 
Hu et al. 2002; Petrovic et al. 2003).
Previous structure–activity relationship 
studies have shown that these compounds bind 
to the nuclear estrogen receptor-α (ER-α) with 
a Ki of 900 nM to 600 mM. The receptor affin-
ity of these alkylphenols increases with increas-
ing chain length of the alkyl groups (Tabira 
et al. 1999). Their binding affinity to nuclear 
ER, as well as their ability to activate nuclear 
ER-α–mediated functions, is several orders of 
magnitude less potent than that of 17β-estradiol 
(E2) (Bonefeld-Jorgensen et al. 2007; Kwack 
et al. 2002; Routledge and Sumpter 1997). 
However, these parameters could be dramati-
cally different for membrane ERs (mERs), 
which are still poorly characterized and func-
tion in a very different micro  environment.
The estrogenic actions of alkylphenol 
compounds are less studied compared with 
BPA (vom Saal and Hughes 2005; Welshons 
et al. 2006); however, several studies clearly   
demonstrated multiple effects of OP and NP, 
such as changes in gene transcription, cell pro-
liferation, and organ development, in a variety 
of cell models (Bonefeld-Jorgensen et al. 2007; 
Soto et al. 1991; Sumpter and Jobling 1993, 
1995; White et al. 1994) and animals (deJager 
et al. 1999a, 1999b; Hewstone 1994; Hossaini 
et al. 2001; Moon et al. 2007; Routledge and 
Sumpter 1997). These researchers noted that 
the estrogenic effects of alkylphenols are evi-
dent at relatively high (0.1–1 µM) concentra-
tions. Unfortunately, many past studies have 
not explored lower doses. At the cellular level, 
little is known about rapid, mER-mediated 
estrogenic effects, which have recently been 
shown to have nonconventional dose–response 
relationships (Watson et al. 2007b), where the 
shape of the curve is nonmonotonic, with more 
than one dose–response peak of activation. 
Therefore, the magnitude of these measurable 
biologic responses does not appear to correlate 
with simple receptor occupancy, but two or 
more different subpopulations of the receptor 
that we do not yet understand (perhaps in dif-
ferent subcellular or submembrane locations) 
could explain this. Such anomalies could also 
be due to the complex, multiple-pathway and 
multistep regulation of cell-signaling events 
initiated by binding to receptors at the plasma 
membrane (Bulayeva et al. 2004).
In our previous study of nongenomic 
xenoestrogen responses in mER-α–enriched 
GH3/B6/F10 somatomammotropes, both 
BPA and NP activated calcium (Ca) signaling 
and prolactin (PRL) release, whereas only NP 
increased extracellular-regulated kinase (ERK) 
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Ba c k g r o u n d: Alkylphenols varying in their side-chain lengths [ethyl-, propyl-, octyl-, and   
nonylphenol (EP, PP, OP, and NP, respectively)] and bisphenol A (BPA) represent a large group of 
structurally related xenoestrogens that have endocrine-disruptive effects. Their rapid nongenomic 
effects that depend on structure for cell signaling and resulting functions are unknown.
oBjectives: We compared nongenomic estrogenic activities of alkylphenols with BPA and 
17β-estradiol (E2) in membrane estrogen receptor-α–enriched GH3/B6/F10 pituitary tumor cells. 
These actions included calcium (Ca) signaling, prolactin (PRL) release, extracellular-regulated 
kinase (ERK) phosphorylation, and cell proliferation.
Me t h o d s : We imaged Ca using fura-2, measured PRL release via radioimmunoassay, detected ERK 
phosphorylation by fixed cell immunoassay, and estimated cell number using the crystal violet assay.
re s u l t s: All compounds caused increases in Ca oscillation frequency and intracellular Ca volume at 
100 fM to 1 nM concentrations, although long-chain alkylphenols were most effective. All estrogens 
caused rapid PRL release at concentrations as low as 1 fM to 10 pM; the potency of EP, PP, and NP 
exceeded that of E2. All compounds at 1 nM produced similar increases in ERK phosphorylation, 
causing rapid peaks at 2.5–5 min, followed by inactivation and additional 60-min peaks (except for 
BPA). Dose–response patterns of ERK activation at 5 min were similar for E2, BPA, and PP, whereas 
EP caused larger effects. Only E2 and NP increased cell number. Some rapid estrogenic responses 
showed correlations with the hydrophobicity of estrogenic molecules; the more hydro  phobic OP and 
NP were superior at Ca and cell proliferation responses, whereas the less hydro  phobic EP and PP 
were better at ERK activations.
co n c l u s i o n s: Alkylphenols are potent estrogens in evoking these nongenomic responses contribut-
ing to complex functions; their hydrophobicity can largely predict these behaviors.
key w o r d s : bisphenol A, calcium oscillation, ERK activation, estradiol, hydrophobicity, non-
genomic response, prolactin release. Environ Health Perspect 117:723–730 (2009).  doi:10.1289/
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phosphorylation (Bulayeva and Watson 2004; 
Stroev et al. 2001; Wozniak et al. 2005) for 
these conditions/time points. These observa-
tions suggested that phenolic xenoestrogens, 
acting through mERs, could have potent 
effects on pituitary cell function via non-
genomic mechanisms, but could also differ in 
some aspects of evoked responses. That low 
concentrations of these phenolic compounds 
with much lower affinity for nuclear ER-α 
still produced potent membrane-initiated 
signaling effects led us to inquire about their 
structure–activity relationships, which were 
likely to be different than those reported for 
nuclear ER-α. In this study, we assessed the 
nongenomic estrogenic activities of four differ-
ent alkylphenols that vary in their side-chain 
lengths (2, 3, 8, and 9 carbons) and hydro-
phobicity, compared with BPA and E2 by test-
ing their rapid effects on Ca signaling, ERK 
activation, cell proliferation, and PRL release 
in GH3/B6/F10 cells.
Materials and Methods
Materials and cell culture. We purchased para-
formaldehyde and glutaraldehyde from Fisher 
Scientific (Pittsburgh, PA) and fura-2 acetoxy- 
methyl ester from Molecular Probes (Eugene, 
OR). The following alkylphenols (purity, 
catalog no.) were purchased from Aldrich 
(St. Louis, MO): EP (99%, no. E44205), PP 
(99%, no. P53802), OP (99%, no. 384445), 
and NP (technical grade, no. 29,085-8). We 
purchased the phosphorylated ERK (pERK) 
antibody (Ab) used in the ERK phosphoryla-
tion studies from Cell Signaling Technology 
(Danvers, MA). All other materials were pur-
chased from Sigma (St. Louis, MO).
We performed all experiments on the 
mER-α–enriched GH3/B6/F10 subclone 
(Pappas et al. 1995) of GH3/B6 pituitary 
somatomammotropes, which are known to 
secrete PRL in response to both thyrotropin-
releasing hormone (TRH) and E2 (Dufy et al. 
1979) and have electrophysiologic properties 
typical of anterior pituitary neuro  endocrine 
cells (Dufy et al. 1979; Glassmeier et al. 2001). 
Cells were maintained at 5% CO2, 37°C in 
phenol red–free Dulbecco’s modified Eagle’s 
medium (DMEM; Mediatech, Herndon, VA) 
with 12.5% horse serum (Gibco BRL, Grand 
Island, NY) and 2.5% defined supplemented 
calf serum and 1.5% fetal bovine serum 
(Hyclone, Logan, UT).
Before experiments, we deprived cells of 
serum steroids by placing them in DMEM 
without serum, with or without defined addi-
tives, or with 4× charcoal-stripped serum (see 
individual experimental descriptions for type 
of medium and length of serum deprivation).
Ca imaging experiments. Before Ca-imaging 
experiments, we harvested cells with 0.25% 
trypsin/0.02% EDTA, plated them on poly-d-
lysine–treated 35/22-mm glass-bottom dishes 
(Willco Wells, Amsterdam, Netherlands) at a 
density of 100,000 cells/mm3, and incubated 
them at 37°C for 48–72 hr. At 12 hr before 
an experiment the medium was changed to 
serum-free, phenol red–free DMEM. On the 
day of the experiment, the cells were loaded 
with 2.5 µM fura-2 acetoxymethyl ester 
(Molecular Probes), a Ca-sensitive fluores-
cent dye (Grynkiewicz et al. 1985), for 1 hr at 
room temperature (RT), washed three times, 
and then maintained at RT for 1–4 hr before 
live Ca-imaging experiments. The physiologic 
solution used for fura-2 loading and live-cell 
imaging contained 150 mM NaCl, 5.5 mM 
KCl, 1 mM MgCl2, 4 mM CaCl2, 7 mM glu-
cose, and 10 mM HEPES, pH 7.4. The cell 
imaging setup included a Nikon 200E micro-
scope with 20× SuperFluo objective and a com-
puter-controlled illumination system (Sutter 
Instruments, Novato, CA) equipped with a 
digital monochrome-cooled charge-coupled 
Roper Coolsnap HQ camera (Roper Scientific, 
Tucson, AZ). We acquired fluorescent emis-
sions at 510 nm (from regions of interest corre-
sponding to a single cell) online with MetaFluor 
software (Universal Imaging, Downington, PA) 
in dual 340/380-nm excitation mode, with 
the 340:380 ratios reflecting cytosolic Ca. We 
used PeakFit and SigmaPlot (Systat Software, 
Chicago, IL) and MetaMorph (Universal 
Imaging) software for conversion and analysis 
of the data.
ERK phosphorylation assay. We previ-
ously developed a 96-well plate assay to assess 
activated ERK-1 and -2 levels in fixed cells 
(Bulayeva et al. 2004), which we used here to 
assess these structurally related alkylphenols. 
Cells were plated at a density of 10,000 cells/
well. The next day, we replaced the growth 
media with DMEM containing 1% 4× char-
coal-stripped serum for 48 hr. Cells were 
then washed with DMEM once before the 
estrogens (or 0.0001% ethanol vehicle con-
trol) were added for 5 min. We then fixed the 
cells with 2% paraformaldehyde/0.2% picric 
acid at 4°C for 48 hr, permeabilized them with 
Figure 2. Rapid effect of E2, BPA, and alkylphenols on cytosolic Ca oscillations. Time-dependent Ca levels 
(340:380 ratio) were recorded from a single representative responding cell for each tested compound. We 
added each estrogen at the 10-min time point at a concentration of 1 nM, as indicated by the arrows.
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Figure 1. Structural similarities among E2, BPA, 
and para-substituted  phenolic  compounds   
[(CH2)n; n = 2, 3, 8, and 9 for the alkyl-phenols in our 
studies] with possible estrogenic activities. The 
phenol backbone of BPA and alkylphenols show 
structural similarity with the hydroxylated phenolic 
A-ring of E2, which appears to be essential for ER 
binding (Tabira et al. 1999). 
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PBS containing 2% bovine serum albumin 
(BSA) and 0.1% Triton X-100 for 1 hr at RT, 
and washed them three times with PBS before 
adding primary Ab against pERK (1:400 in 
PBS/1% BSA/0.1% Triton X-100). After over-
night incubation at 4°C, the cells were washed 
three times with PBS and the biotin-conjugated 
secondary Ab (Vector Labs, Burlingame, CA; 
1:300) in PBS/1% BSA was added for 1 hr at 
RT. The cells were again washed with PBS, 
incubated with Vectastain ABC-AP solution 
(Vector Labs) for 1 hr at RT, and again washed 
three times with PBS, followed by addition 
of Vectastain alkaline phosphatase substrate 
plus levamasole (an endogenous phosphatase 
inhibitor). We incubated plates in the dark 
for 30 min at 37°C and then read the signal 
for the phosphatase product para-nitrophenol 
(pNP) at 405-nm absorbance (A405) in a model 
1420 Wallac microplate reader (Perkin Elmer, 
Waltham, MA). We determined the number 
of cells in each well by the crystal violet (CV) 
assay.
PRL release measured via radio  immuno­
assay. Cells (0.5–0.7 × 106) were plated in poly-
d-lysine–coated six-well plates. After serum 
deprivation in DMEM containing 5 µg/mL 
insulin, 5 µg/mL transferrin, 5 ng/mL sodium 
selenite, and 0.1% BSA for 48 hr, we removed 
this medium and added new DMEM/0.1% 
BSA with or without the appropriate reagent or 
vehicle control (ethanol). The cells were incu-
bated for 1 min and centrifuged at 4°C, 350 × 
g for 5 min. We then collected the supernatant 
and stored it at –20°C until radioimmuno-
assay (RIA) for PRL, and fixed the cells for 
cell number estimation with the CV assay (see 
below). Concentrations of PRL were deter-
mined using components of the rat PRL RIA 
kit from the National Institute of Diabetes and 
Digestive and Kidney Disease and the National 
Hormone and Pituitary Program (Baltimore, 
MD). Briefly, we combined 100 µL cold 
standard (rat PRL-RP-3) or unknown sam-
ple, 500 µL rPRL-s-9 antiserum [final dilu-
tion of 1:437,500 in RIA buffer containing 
80% phosphate-buffered saline (PBS), 20% 
DMEM, and 2% normal rabbit serum], and 
200 µL 125I-labeled rat PRL (Perkin Elmer, 
Wellesley, MA; using 15,000 counts/tube 
diluted in RIA buffer), which we incubated 
with shaking overnight at 4°C. Anti-rabbit 
IgG was added (200 µL of 1:9 final dilution 
in RIA buffer) and the samples were incubated 
with shaking at RT for 2 hr. We then added 
1 mL polyethylene glycol (PEG) solution (1.2 
M PEG, 50 mM Tris, pH 8.6)and incubated 
the samples with shaking at RT for 15 min. 
The samples were centrifuged at 4,000 × g for 
10 min at 4°C, the supernatant decanted, and 
the pellet counted in a Wizard 1470 Gamma 
Counter (Perkin Elmer). We calculated the 
PRL concentration and normalized it to the 
CV values representing cell number.
Cell number measurements: CV assay. We 
assessed cell numbers for proliferation studies, 
or normalization of the above assay results, by 
washing any other detection reagents or growth 
medium from the wells and then staining the 
cells with CV dye. CV stains multiple cellu-
lar constituents, with values proportional to 
cell numbers measured with other techniques 
(Zivadinovic et al. 2005). For prolifera  tion 
studies, cells were plated at 5,000 cells/well 
onto poly-d-lysine–coated wells of a 96-well 
plate. The next day, we added growth media 
with 1% 4× charcoal-stripped serum with or 
without the different xeno  estrogens or vehicle. 
After 72 hr, cells were fixed for 20 min in 2% 
paraformaldehyde and 0.1% glutar  aldehyde in 
PBS, stained for 30 min with a 0.1% solution 
of CV, and destained in deionized water. The 
dye was released by 10% acetic acid at RT for 
30 min and the A590 signal of the extract was 
read in a microplate reader.
Statistics. We analyzed data from the meas-
urements of PRL release, cell proliferation, and 
the pERK assay by one-way analysis of vari-
ance (ANOVA) followed by multiple com-
parisons versus the control group (Dunnett’s 
method). Paired t-tests were used to compare 
Ca signaling characteristics before and after 
various estrogen treatments, and an ANOVA 
with the Dunn’s method for multiple compari-
sons was used for the different treatment series. 
The SigmaStat 3.0 program (Systat Software, 
Chicago, IL) was used for all statistical analyses. 
We accepted significance at p < 0.05.
Results
Alkylphenol xenoestrogens activate cytosolic 
Ca oscillations. Fura-2–loaded GH3/B6/F10 
mER-α–enriched cells showed functional   
heterogeneity typical for this cell line (Bulayeva 
et al. 2005) and its parental cell line (Dufy 
et al. 1979; Glassmeier et al. 2001); 30–50% 
of simultaneously recorded cells generated 
some level of spontaneous Ca oscillations at a 
frequency from 0.1–10 spikes/min. To com-
pare the changes in Ca responses caused by E2 
and BPA with those caused by different alkyl-
phenolic xenoestrogens, we treated cells with 
different concentrations of these compounds 
ranging from 1 fM to 1 nM. Figure 2 shows 
representative Ca traces recorded from single 
cells demonstrating significant increases in Ca 
oscillation frequencies after addition of 1 nM 
of each estrogen. As we observed previously in 
comparisons of E2 with estriol (E3) and estrone 
(E1) (Watson et al. 2008), there was a highly 
variable and relatively long (30 sec to several 
minute) delay in the response, but with no 
significant differences in this latency between 
treatment groups (data not shown). Responses 
to estrogens were typically observed in cells 
that already demonstrated some pretreatment 
level of spontaneous Ca firing (monitored dur-
ing 10 min of recording); silent cells under 
these control conditions only rarely showed 
a response after treatment with an estrogen. 
Therefore, in subsequent analyses, we evalu-
ated only cells that showed some spontaneous 
activity in prerecordings.
Quantitation of different aspects of estrogen­ 
induced Ca responses: dose responses and 
structure–activity relationships. Figure 3A 
quantifies the percentage of cells demonstrating 
increased Ca oscillation frequency in response 
Figure 3. Quantitation of different aspects of estrogen-induced Ca responses. (A) The number of responding cells calculated as a percentage of total number of 
cells assessed in a given dish, recorded simultaneously (3–5 different dishes, 54–228 cells for each data point). (B) Changes in Ca oscillation frequency (average 
number of Ca peaks per minute, measured over 10 min) compared with the average baseline frequency before any estrogen treatment (Con). n = 11–33 individual 
cells for each point. (C) The integral of the Ca response to estrogens or vehicle-treated controls (Con), measured as the total area under the Ca peaks, recorded 
over 10 min. We subtracted the baseline pretreatment Ca levels. 
*p < 0.05 compared with vehicle control. #p < 0.05 compared with E2.
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to E2 or xenoestrogen treatment. E2 at concen-
trations from 1 fM to 1 nM increased the Ca 
firing rate in a significantly larger number of 
cells than did vehicle treatment, with the maxi-
mal effect at concentrations from 100 fM to 
1 nM (where 60–70% of cells responded). As 
we found in an independent set of experiments, 
E2 increased average number of Ca-firing cells 
30% per dish (data not shown; p < 0.05, n = 4).
The alkylphenol xenoestrogens were 
not quite as effective as E2 in eliciting a cell 
response; the lowest concentration that caused 
a significant increase as estimated by multiple 
comparison statistics was 100 fM for EP and 
PP, 10 pM for BPA, and 1 nM for OP and 
NP. However, t-test statistics showed a signifi-
cant effect at concentrations as low as 1 fM for 
OP and BPA and 100 fM for OP and BPA; 
responses continued for these compounds at 
higher concentrations with some exceptions. 
The percentages of cells responding to these 
xenoestrogens were typically smaller than for 
E2 across all concentrations, rarely exceed-
ing 40–50%. The magnitude of the response 
tended to increase with increasing concentra-
tions of BPA and the long-chain alkyl  phenols 
OP and NP, but peaked and declined for the 
short-chain compounds EP and PP.
Figure 3, B and C, provides further evi-
dence for differences in quantifiable Ca 
responses in GH3/G6/F10 cells to structurally 
different alkylphenols, compared with E2. We 
compared the dose dependence of estrogen-
induced changes in Ca oscillation frequency, as 
well as the total magnitude of the Ca response 
(measured as the total area of the Ca spikes, or 
the ΔCa integral). We calculated these param-
eters only for responding cells over a 10-min 
interval. These dose–response curves were gen-
erated slightly differently from those reported 
in our previous study that included E2, NP, 
and BPA (Wozniak et al. 2005), as here each 
dose was analyzed with entirely indepen-
dent treatments of different cell preparations, 
rather than multiple treatments of the same 
cells. Thus, we eliminated possible artifacts of 
delayed changes in cell responsiveness due to 
a prior treatment. Such effects can alter the 
number or functional state of plasma mem-
brane receptors, or downstream effectors after 
repeated stimulation (desensitization). For both 
the Ca firing rates and the amounts of Ca get-
ting into the cells, the long-chain alkylphenols 
OP and NP were more effective than E2 at 
many concentrations and largely comparable at 
others. Many of the responses (except to BPA) 
show a biphasic dose dependence (declining at 
the higher concentrations). They also appear in 
many cases to be all-or-nothing phenomena, 
as we saw previously for the other physiologi-
cal estrogens, E1 and E3 (Watson et al. 2008). 
Overall, these studies indicate that the xeno- 
estrogens not only were as potent and effective 
as E2, but in some cases evoked this response 
significantly better than E2, especially if the 
chain length was eight carbons.
Rapid effects of alkylphenols on PRL 
release. Because an increase in Ca firing in neu-
roendocrine cells activates peptide hormone 
secretion by priming and triggering secre-
tory granule release, it would be reasonable 
to expect from the data shown in Figures 2 
and 3 that the alkylphenols and BPA may 
have a rapid E2-like effect on PRL secretion 
by pituitary cells. As shown in Figure 4, E2 
and the short-chain alkylphenols EP and 
PP showed very similar dose-dependent   
stimulating effects on PRL release by GH3/B6/
F10 cells after a 1-min incubation at a concen-
tration range from 100 fM to 100 pM. The 
overall characteristics of the responses were sim-
ilar for all six compounds, with the responses 
disappearing in approximately the 1–10 nM 
range (even though for BPA and NP this was 
a trend and not strictly signi  fi  cant by the same 
tests). Both long- and short-chain alkylphenols 
were relatively potent in this response, with EP 
and NP causing responses at the lowest con-
centration (10–15 M). Therefore, differences 
here did not seem to correlate directly with 
the carbon chain length of the alkyl modifica-
tion. This level of potency exceeds that of E2 by   
several orders of magnitude. Despite some dif-
ferences in the most effective dose ranges, the 
magnitude of xenoestrogen- and E2-induced 
rapid PRL release was very similar.
Alkylphenol xenoestrogens rapidly increase 
ERK phosphorylation. In a previous study, 
we demonstrated that E2 and several xeno-
estrogen compounds of different classes rap-
idly activate ERKs by phosphorylation in 
GH3/B6/F10 prolactinoma cells with distinct 
dose dependence and temporal activation 
patterns. Here, we compared the ability of a 
structurally related set of compounds to elicit 
this response. As shown in Figure 5A, most 
tested compounds produced characteristic 
oscillating increases in pERK with one rapid 
peak at 2.5–5 min (lasting only a few min-
utes), followed by a second slow, continuous 
increase reaching statistically significant levels 
in most cases at 60 min. Although short-chain 
Figure 4. Concentration dependence of estrogen-induced rapid changes in PRL secretion. We measured 
PRL released into the medium by RIA after 1 min of treatment with E2, BPA, EP, PP, OP, or NP at different 
concentrations (n = 12–24 for each data point). 
*p < 0.05 versus vehicle control (Con; n = 32).
160
140
120
100
160
140
120
100
160
140
120
100
160
140
120
100
160
140
120
100
160
140
120
100
Con –15 –14 –13 –12 –11 –10 –9 –8 –7 –6 Con –15 –14 –13 –12 –11 –10 –9 –8 –7 –6
Con –15 –14 –13 –12 –11 –10 –9 –8 –7 –6 Con –15 –14 –13 –12 –11 –10 –9 –8 –7 –6
Con –15 –14 –13 –12 –11 –10 –9 –8 –7 –6 Con –15 –14 –13 –12 –11 –10 –9 –8 –7 –6
*
*
*
*
*
*
*
*
*
* *
*
*
*
*
*
* *
*
* *
* *
*
* *
Concentration [log (M)] Concentration [log (M)]
Concentration [log (M)] Concentration [log (M)]
Concentration [log (M)] Concentration [log (M)]
P
r
o
l
a
c
t
i
n
 
r
e
l
e
a
s
e
d
 
(
%
 
o
f
 
c
o
n
t
r
o
l
)
P
r
o
l
a
c
t
i
n
 
r
e
l
e
a
s
e
d
 
(
%
 
o
f
 
c
o
n
t
r
o
l
)
P
r
o
l
a
c
t
i
n
 
r
e
l
e
a
s
e
d
 
(
%
 
o
f
 
c
o
n
t
r
o
l
)
P
r
o
l
a
c
t
i
n
 
r
e
l
e
a
s
e
d
 
(
%
 
o
f
 
c
o
n
t
r
o
l
)
P
r
o
l
a
c
t
i
n
 
r
e
l
e
a
s
e
d
 
(
%
 
o
f
 
c
o
n
t
r
o
l
)
P
r
o
l
a
c
t
i
n
 
r
e
l
e
a
s
e
d
 
(
%
 
o
f
 
c
o
n
t
r
o
l
)
E2 BPA
EP PP
OP NP
*
* *
*Alkylphenols evoke nongenomic estrogenic responses
Environmental Health Perspectives  •  v o l u m e  117 | n u m b e r 5 | May 2009  727
alkylphenols, as well as E2 and BPA, produced 
comparable 10–15% increases in ERK phos-
phorylation at 2.5–5 min, the longer-chain 
compounds did not cause a statistically signi-
ficant initial rise, so again, there were distinct 
differences based on chain length. BPA did 
not produce a significant second peak here, 
and also was not as effective as other com-
pounds in our previous studies (Bulayeva and 
Watson 2004).
Figure 5B compares the dose dependence 
of the rapid ERK activation at 5 min. BPA 
and PP produced 10–20% increases in pERK 
with nonmonotonic dose–response character-
istics. The magnitude of the effect exceeded 
that caused by E2, which showed a simi-
larly shaped response curve. EP caused only 
a simple plateauing of the response curve, 
with no sensitivity to lower concentrations. 
However, the long-chained alkylphenols OP 
and NP caused no significant changes at this 
time point, in contrast to the significant NP 
dose–response changes at 30 min, which we 
reported previously (Bulayeva and Watson 
2004). This result emphasizes the fact that 
we often see entirely different dose–response 
relationships at different time points for these 
oscillating responses. Overall, we again see 
a striking difference between the two chain-
length subcategories of alkylphenols.
Cell proliferation. Despite the promi-
nent effect that some compounds had on 
ERK phosphorylation, this did not correlate 
as expected with the effects on cell number 
(Figure 6). Although E2 had only a moderate 
effect on ERK phosphorylation compared 
with other compounds, it had the most strik-
ing effect on cell proliferation. At concen-
trations as low as 10 fM, E2 increased cell 
number up to 24% in 3 days, a remarkable 
sensitivity that has been previously observed 
for another rat lactotroph cell line (Chun 
and Gorski 2000). Most of the tested xeno-
estrogens had no (PP and EP) or little (OP 
and BPA) effect on cell number (only at 
the very highest concentrations). The nota-
ble exception was NP: 10 pM and above 
increased cell number 8.5–15% but had no 
effect on ERK phosphorylation (Figure 5B).
Hydrophobic properties of xenoestrogen 
molecules and their rapid effects on cell sig­
naling and function: structure–activity cor­
relations. Figure 7 compares all of these rapid 
cellular signaling and functional responses to 
structurally related xenoestrogens by increasing 
hydrophobicity. Hydrophobicity was estimated 
as the logarithm of octanol–water partition 
coefficient (log Kow) taken from the PubChem 
database (National Center for Biotechnology 
Information, 2009). Short-chain alkylphenols 
such as EP and PP have relatively low log 
Kow values, and long-chain OP and NP are 
relatively highly hydrophobic. E2 and BPA, 
although have no side chains, are similar to 
each other both in structure (multiple carbon 
rings) and are intermediate in hydro  phobic 
value. We chose this analysis, compared with 
the carbon-chain-length comparison used 
frequently in the literature (Kwack et al. 
2002), to formally include compounds with-
out side chains in our characterization. Some 
Figure 5. Changes in ERK phosphorylation in response to E2, BPA, EP, PP, OP, and NP. Values are the amount of pNP generated for each well, normalized to the 
CV value for cell number, presented as a percentage of vehicle-treated controls (Con), which we set to 100. (A) Time-dependent changes in the phosphorylation 
status of ERKs due to 1 nM estrogen treatments (n = 24 samples over three experiments). (B) Concentration-dependent changes in the phosphorylation status of 
ERKs after 5-min estrogen treatments (n = 32 samples over four experiments).
*p < 0.05 versus control.
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Figure 6. Proliferative response to E2, BPA, and 
alkylphenols measured by the CV assay. We grew 
cells in the presence of different concentrations of 
E2 or xenoestrogens for 3 days. Proliferation at day 
3 is cell number as a percentage of vehicle control 
(Con). n = 24 samples over three experiments. 
*p < 0.05 versus control.
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simplifications were employed for displaying 
all these data together, mainly based on lim-
iting concentrations to those causing near-
maximal responses. Because most of the Ca 
responses were dose independent (all-or-none 
and within these response groups not statisti-
cally different from one another), we com-
bined these data to examine the dependence 
on this chemical feature (Figure 7A, B). For 
the PRL release data (Figure 7C), 100 pM 
is shown, and for the proliferative response 
(Figure 7F), 10 pM to 10 nM treatments 
were averaged, because they were near maxi-
mal for all tested compounds (Figure 4). For 
the ERK phosphorylation response at both 5 
and 60 min (Figure 7D, E), we used the same 
concentration as for the time courses, because 
this particular dose consistently produced the 
most similar biphasic temporal patterns of 
response for all compounds. This also allowed 
us to compare responses at two time points for 
  different estrogens.
For producing increases in the Ca firing 
rate, the more hydrophobic, long-chain alkyl-
phenols OP and NP were generally equally 
active, although OP was significantly better 
(Figure 7A) than the short-chain EP and PP 
and extra-ring-structure compounds (BPA and 
E2). Although multiple comparisons tests did 
not show a statistical difference between NP 
and the other compounds, it was significantly 
more effective than EP, PP, and E2 by a t-test. 
Only OP was significantly better at increasing 
the volume of Ca entering cells (Figure 7B). 
Although the direct correlation between the 
Ca response parameters and log Kow values 
by Pearson’s test were not statistically sig-
nificant (p = 0.293 for ΔCa integral and 
p = 0.066 for Ca oscillation frequency), by 
Spearman’s rank correlation test the increase 
in hydro  phobicity from “low” (EP and PP) 
to “medium” (E2 and BPA) to “high” (OP) 
does significantly correlate with changes in Ca 
oscillation frequency (p = 0.017). No obvious 
dependence on the chemical properties of the 
xeno  estrogen molecules was seen for rapid 
PRL release (Figure 7C), except that BPA was 
significantly less effective than the most effec-
tive compounds (PP and NP).
In contrast to the structural dependency 
of Ca changes, we observed a surprisingly 
strong inverse correlation between molecule 
hydrophobicity and the first (5 min) peak of 
ERK phosphorylation (p = 0.004, Pearson 
test; Figure 7D). No obvious dependence 
on chemical properties was observed for the 
second (60 min) ERK phosphorylation peak 
(Figure 7E). However, E2 and BPA again 
clustered together, being far less effective than 
would have been predicted by their hydro-
phobicity scores.
E2 and NP were the most effective 
compounds at causing cells to proliferate 
(Figure 7F) with a positive correlation with 
hydrophobicity (p = 0.03, Pearson test), and 
no correlation with their ERK activation pro-
files at either time point. The magnitude of 
the E2 effect was much larger than its hydro-
phobicity would have predicted and higher 
than for any other compound tested.
Discussion
Our studies demonstrate the abilities of both 
short- and long-carbon-chain para-alkyl  phenols, 
as well as BPA, to potently and effectively cause 
nongenomic estrogenic responses in pituitary 
tumor cells. In many of these responses, the 
xenoestrogens were equivalent to or more 
potent and effective than E2. This clearly shows 
that these compounds are not “weak” estro-
gens, as they have been shown to be for many 
genomic responses (Bonefeld-Jorgensen et al. 
2007; Soto et al. 1991; Sumpter and Jobling 
1993,1995; White et al. 1994).
These xenoestrogens increased the fre-
quency of Ca oscillations and also increased the 
total cytosolic Ca concentrations in GH3/B6/
F10 somatomammotropes, similar to our pre-
vious results for NP and BPA using escalating 
treatment concentrations on the same cultures 
(Bulayeva et al. 2005). Our previous studies 
demonstrated that the increase in Ca influx 
observed within minutes of E2, BPA, and NP 
application is strictly dependent on mER-α 
and mediated by L-type voltage-gated Ca chan-
nels; EP, PP, and OP likely use a similar cellu-
lar machinery to mediate their responses.
Because our GH3 cell subline was pre-
viously determined not to contain ER-β 
(Norfleet et al. 1999) or G-protein–coupled 
receptor 30 (Thomas et al. 2005) under these 
culturing conditions, these receptors are not 
likely involved in the responses we describe 
here. Other closely related receptors that 
are less well characterized [e.g., the nuclear 
estrogen-related receptor-γ (ERRγ); Eudy 
et al. 1998] may participate in Ca and other 
responses to some xenoestrogens. ERRγ has 
Figure 7. Rapid signaling responses elicited by various alkylphenols, BPA, and E2, by increasing hydro- 
phobicity. Responses are ordered by hydrophobicity indices; the numbers next to each symbol are carbon 
atoms in each compound’s side chain (where applicable). (A) Ca oscillation frequency (averaged for 1 fM 
to 1 nM treatments). *p < 0.05 compared with E2, EP, and PP. (B) Integral (volume) of the Ca response 
(averaged for 1 fM to 1 nM treatments). *p < 0.05 compared with E2 and PP. (C) PRL secretion activated by 
100 pM treatment. *p < 0.05 compared with PP and NP. (D and E) ERK activation response to 1 nM treat-
ments measured at 5 and 60 min, respectively. *p < 0.05 compared with OP; #p < 0.05 compared with NP. 
(F) Proliferative response (averaged for 10 pM to 10 nM treatments). *p < 0.05 compared with all other 
tested compounds; #p < 0.05 compared with EP and PP for OP, compared with PP for BPA.
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a much higher affinity for BPA and EP (Liu 
et al. 2007; Okada et al. 2008) and could 
contribute to these results. The possibility of 
different receptor involvement could explain 
other observations by Woclawek-Potocka et al. 
(2006) that EP did not affect Ca signaling in 
the endometrium but did affect prostaglandin 
F2α production, whereas E2 affected both. 
A relatively long (several minutes) and 
highly variable delay between the application 
of the estrogens and their observed effects 
on increasing the Ca oscillation frequency, 
as well as the lack of a clear concentration 
dependence of the response magnitudes, sug-
gests that the mechanism of estrogen and 
xenoestrogen action on Ca signaling involves 
multiple intracellular events. These probably 
include phosphorylation of multiple signal-
ing proteins and their targets by numerous 
different kinases, and perhaps also changes 
in membrane excitability. The fact that only 
spontaneously active cells (generating episodic 
Ca waves without any stimulation) typically 
responded to these estrogens indicates indi-
rectly that E2 and these xenoestrogens may 
elicit their actions by changing resting poten-
tials. Because a major mechanism for regu-
lation of membrane excitability in pituitary 
lactotropes is potassium channel modulation 
caused by TRH (Bauer 1998), crosstalk is 
likely with its signaling pathways for induc-
ing these estrogen/xenoestrogen-mediated 
Ca responses. One interesting direction for 
further studies would be a more thorough 
examination of the possible crosstalk between 
multiple signaling pathways activated by 
E2 and xenoestrogens, as suggested by our 
previous work (Bulayeva et al. 2004, 2005; 
Wozniak et al. 2005).
Despite the relatively long lag time for 
estrogen-induced Ca firing changes, the rapid 
effect on PRL release is completed within 
1 min. These data suggest that besides activa-
tion of Ca signaling, estrogens regulate PRL 
release through additional rapid mechanisms, 
probably related to secretory granule matura-
tion, and docking and priming, as we demon-
strated previously by showing that very large 
Ca effects do not necessarily cause very large 
secretory responses (Bulayeva et al. 2005). 
Further study of these possible mechanisms 
would contribute to our understanding of 
estrogen- and xenoestrogen-dependent regu-
lation of endocrine functions. In addition, 
limitations of the fura-2 technique undoubt-
edly contribute to our inability to precisely 
detect fast and local Ca transients in these 
experiments. Further studies employing mem-
brane Ca-current patch-clamp recording and 
advanced microscopic techniques that allow 
us to observe the near-membrane Ca domain 
could provide further details of how estrogens 
activate Ca signaling events, which in turn 
influences quantal PRL release.
The functional consequences of activat-
ing the ERK cascade in these cells cannot eas-
ily be related to cell proliferation as in some 
other systems (Meloche and Pouyssegur 2007). 
Overall, the biphasic time courses of ERK 
responses were similar between these alkyl-
phenols and E2, suggesting common signaling 
pathways initiated at the mER-α. Other classes 
of xenoestrogens (the chlorinated pesticides 
dichlorodiphenyldichloro-ethylene, dieldrin, 
and endosulfan) that we previously studied 
elicited very different time courses of ERK acti-
vation and were differentially dependent upon 
upstream kinases at different times (Bulayeva 
and Watson 2004). With the exception of EP, 
these compounds showed an inverse correla-
tion between the magnitude of their usually 
proliferation-related ERK activation at 60 min 
(PP > OP > NP > E2 > BPA) and their bind-
ing affinity for the artificially expressed nuclear 
receptor reported in the literature (Bonefeld-
Jorgensen et al. 2001; Kwack et al. 2002; 
Routledge and Sumpter 1997). Therefore, 
the rules for potency and effectiveness via the 
mER-α versus the nuclear ER appear to be dif-
ferent. These data may suggest that the effects 
of estrogens on pituitary tumor cell prolifera-
tion are realized via distinct or additional path-
ways. Our other recent data suggest additional 
pathways, because blocking estrogenic acti-
vation of ERKs and other mitogen-activated 
protein kinases blocks cell proliferation in these 
cells (Jeng Y-J and Watson CS, unpublished 
data). Assessment of changes in mitotic activ-
ity, apoptosis, cell attachment, and motility 
may further our understanding of these differ-
ential estrogenic effects on this cell type’s abil-
ity to proliferate. Properties of these molecules 
other than hydrophobicity may affect their 
ability to activate ERK signaling, and the func-
tional consequences of ERK signaling may not 
include or extend beyond cell proliferation.
Multiple aspects of rapid mER-mediated 
signaling in pituitary cells do not consistently 
correlate with the affinity of xenoestrogen 
molecules to the artificially produced nuclear 
form of this receptor (Bonefeld-Jorgensen 
et al. 2007; Kwack et al. 2002; Routledge 
and Sumpter 1997). In some cases we even 
observed a reverse dependence, as in the case of 
the delayed (60 min) ERK activation. As is evi-
dent from our dose–response curves describing 
effects of xenoestrogens on Ca signal  ing and 
PRL release, the active concentrations needed 
to produce a response (100 fM to 1 nM) were 
far below those reported in the literature for 
alkylphenol and BPA genomic responses. 
These concentrations are also far lower than 
those reportedly required for half-maximal 
binding to heterologously expressed and/or 
purified ER reporter gene activation. This dif-
ference is likely explained by distinct ligand-
binding properties of mER-α due to structural 
differences (posttranslational modifications; 
Li et al. 2003) or a dramatic impact of the 
microenvironment (membrane border lipid 
contact). This emphasizes the importance of 
further structural/functional studies specifi-
cally on mER-α, because its ligand inter  actions 
appear to be dramatically different from those 
of the cytosolic/nuclear receptor.
Structure-based activity models of chemi-
cal endocrine disruptors would be very helpful 
for safety screening and predictions of expo-
sure outcomes (Devillers et al. 2006). This 
might be particularly important for mem-
brane receptor activation, because the rules 
affecting receptor affinity and activity may be 
different and are as yet little explored. Our 
data suggest that the ability of xeno  estrogens 
to elicit rapid Ca and ERK phosphorylation 
responses in pituitary cells depends on hydro-
phobicity, which is somewhat dependent 
upon the length of linear carbon chains, rather 
than with their ability to bind nuclear recep-
tor in artificial binding systems. The Ca and 
ERK responses correlate with hydrophobicity 
in the opposite way: the more hydrophobic 
the compound, the bigger the Ca changes 
but the less ERK phosphorylation produced. 
This may suggest that different conforma-
tional states of mER-α caused by the dock-
ing of differently shaped ligands, as well as 
their induced membrane microenvironment 
changes, might dictate different interactions 
with other signaling molecules and thus dif-
ferent biologic response propensities.
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